Third Quarter Earnings Increase to Record High
BEDFORD, Mass., July 30 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX), a diversified medical technologies company specializing in diagnostics, imaging products and interventional devices dedicated to serving the healthcare needs of women, today announced its results for the quarter ended June 28, 2008.
Highlights of the quarter include:
-- Revenues of $429.5 million.
-- Record 429 Selenia full field digital mammography systems installed and recognized as revenue.
-- NovaSure revenues bounced back to $56.3 million, while reducing field inventory and increasing the backlog of standing orders.
-- Third quarter 2008 diluted earnings per share (EPS) calculated in accordance with generally accepted accounting principles in the U.S. (GAAP) were $0.24. Third quarter 2008 non-GAAP adjusted EPS were $0.33. A reconciliation of our GAAP to non-GAAP results is included as an attachment to this press release.
-- Announcement of Third Wave Technologies acquisition (subsequently completed on July 24, 2008).
-- Term loan balance reduced to zero at June 28, 2008 (additional borrowings made in July to fund Third Wave acquisition).
Third quarter fiscal 2008 revenues totaled $429.5 million, a 124%
increase when compared to revenues of $191.5 million in the third quarter
of fiscal 2007. The increase was primarily attributable to the inclusion of
approximately $191.5 million of revenues from the new product lines
acquired in the merger with Cytyc Corporation on October 22, 2007. For the
third quarter of fiscal 2008, Hologic reported net income of $61.4 million,
or $0.24 per diluted share, compared with net income of $24.7 million, or
|SOURCE Hologic, Inc.|
Copyright©2008 PR Newswire.
All rights reserved